PMID: 25782201Jan 1, 2014Paper

Erythropoiesis stimulating agents in clinical practice

Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Longin Niemczyk, Małgorzata Dębowska

Abstract

Anemia is one of the most common problems of patients with advanced chronic kidney disease (CKD). Its main causes in this population are: iron deficiency and a decreased renal synthesis of erythropoietin. Up to the 80's of the twentieth century, treatment of anemia in CKD was limited to blood and red blood cells transfusions. However during last three decades there has been a huge progress in the field, starting with introduction into clinical practice of human recombinant erythropoietin (rHuEPO), followed by an appearance of agents with a longer duration of action, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta, all of which are shortly reviewed in this paper.

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

The Cochrane Database of Systematic Reviews
Suetonia C PalmerGiovanni F M Strippoli
Pediatrics International : Official Journal of the Japan Pediatric Society
Ceren CanAydan Şirin
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Maria Wanic-Kossowska
The Cochrane Database of Systematic Reviews
Thomy ToniaJulia Bohlius
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Iain C MacdougallNESP 960245/246 Study Group
© 2021 Meta ULC. All rights reserved